Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 25, 2019 Off

AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

By BusinessWire

Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on…

March 25, 2019 Off

Global Ophthalmics Partnering 2014-2019: Financial Deal Terms for Headline, Upfront and Royalty by Stage of Development – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics…

March 25, 2019 Off

Xeris Pharmaceuticals Presents New Clinical and Economic Impact Data on Its Developmental Ready-to-Use Glucagon

By BusinessWire

Data from a Phase 2 study in congenital hyperinsulinism (CHI) shared at ENDO 2019 and a budget impact model presented…

March 25, 2019 Off

Turning Point Therapeutics Appoints Jim Mazzola to Lead Corporate Communication and Investor Relations

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance,…

March 25, 2019 Off

Global Sensory Organ Partnering Deals Directory 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Sensory Organ Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global…

March 25, 2019 Off

Global Genetic Disorders Partnering Deal Trends, Players and Financials 2014-2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Genetic disorders Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global…

March 25, 2019 Off

CEL-SCI Corporation Releases Letter to Shareholders

By BusinessWire

VIENNA, Va.–(BUSINESS WIRE)–The following letter was sent by CEL-SCI Corporation (NYSE American: CVM) to its shareholders for the upcoming annual…

March 25, 2019 Off

Cortexyme to Present Preclinical and Clinical Data Supporting Its Novel Investigational Alzheimer’s Treatment At AD/PD 2019

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc., a privately held, clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…

March 25, 2019 Off

Advaxis Granted U.S. Patent Relating to Axalimogene Filolisbac

By BusinessWire

Currently in a Phase 3 Pivotal Study for High-Risk Locally Advanced Cervical Cancer PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS) (the Company),…

March 25, 2019 Off

Arch Oncology Raises $50 Million Series B Financing

By BusinessWire

— Financing to Advance Lead Anti-CD47 Antibody AO-176 in Ongoing Phase 1 Clinical Trial and Pipeline — BRISBANE, Calif. and…

Posts pagination

Previous 1 … 3,335 3,336 3,337 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine